NOXXON Pharma NV is to test its RNA oligonucleotide drug NOX-A12 in a new cancer indication after signing an agreement with an unidentified large pharma company to conduct preclinical studies of the drug. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
